Home › NDC Lookup › RxCUI directory › RxCUI 2670184

Fruquintinib 1 MG Oral Capsule — RxCUI 2670184

RxNorm drug concept · Semantic clinical drug
RxCUI 2670184 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2670184
Official nameFruquintinib 1 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)323 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fruquintinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Fruzaqla contains the active ingredient fruquintinib, and it's designed specifically for adults whose colorectal cancer has spread and who have already tried several rounds of stan...
  • What exactly is Fruzaqla and why was it prescribed to me?
  • You take one capsule by mouth once a day — swallowed whole — for the first 21 days of every 28-day cycle. Then you take 7 days off before the next cycle starts. The good news is fo...
  • How do I take it, and does it matter if I take it with food?
📖 Read our full Fruquintinib guide →

🕸️ Concept Web — How Fruquintinib 1 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fruquintinib 1 MG Oral Capsule RxCUI 2670184

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fruquintinib 2670179
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fruzaqla 2670185
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fruquintinib Oral Capsule 2670183
    • Fruquintinib Oral Product 2670181
    • Fruquintinib Pill 2670182
    • Fruquintinib Oral Capsule [Fruzaqla] 2670189
    • Fruzaqla Oral Product 2670187
    • Fruzaqla Pill 2670188
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fruquintinib 1 MG SCDC · 2670180
  • Fruquintinib Oral Capsule SCDF · 2670183
  • Fruquintinib Oral Product SCDG · 2670181
  • Fruquintinib Pill SCDG · 2670182

Brand-Name Concepts

  • Fruquintinib 1 MG Oral Capsule [Fruzaqla] SBD · 2670190
  • Fruquintinib 1 MG [Fruzaqla] SBDC · 2670186
  • Fruquintinib Oral Capsule [Fruzaqla] SBDF · 2670189
  • Fruzaqla Oral Product SBDG · 2670187
  • Fruzaqla Pill SBDG · 2670188
  • Fruzaqla BN · 2670185

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2670184 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63020-0210-21 1 BOTTLE in 1 CARTON (63020-210-21) / 21 CAPSULE in 1 BOTTL... Fruzaqla Takeda Pharmaceuticals America, Inc. 2023-11-08
63020-0225-21 1 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTL... Fruzaqla Takeda Pharmaceuticals America, Inc. 2023-11-08
Observed labelers: Takeda Pharmaceuticals America, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.